Shima Hadidchi, MD , explains that Zepbound is a medication that goes beyond traditional GLP-1 treatments
Federal programs currently are prohibited from covering any drugs intended for weight loss. The Biden administration proposed reinterpreting a federal rule to allow coverage of drugs specifically for the treatment of obesity
These adverse effects have led to numerous lawsuits against Novo Nordisk, alleging that the company failed to adequately warn users about the potential risks associated with Semaglutide
And there was only one problem with that very beautiful theory, which was correct, by the way, and that was that proglucagon had to be bigger than what we had found
This matters even more with long-lasting options like Semaglutide and Tirzepatide
The negotiated price is a significant cut from the drugs list prices: The list price for Ozempic is $997, Wegovy is $1,350, Mounjaro is $1,080, and Zepbound is $1,086